Timur Yarovinsky

Company: CaroGen Corporation

Job title: VP Drug Discovery, Director of Immunology

Seminars:

Development of CARG-2020, a Synthetic Oncolytic & Immunomodulating Virus, for Treatment & Prevention of Solid Tumors 3:30 pm

Providing an overview of CARG-2020, a synthetic oncolytic and immunomodulating virus designed for the treatment and prevention of solid tumors Discussing the advantages of developing synthetic viruses, including improved safety profiles, enhanced tumor targeting capabilities, and the ability to incorporate multiple therapeutic functionalities Addressing the safety considerations of CARG-2020, including its replication selectivity for tumor…Read more

day: Day One